admin | April 28, 2021
Researchers Ann Mullally (prior MPNRF grantee) and Adam Mead have pubilshed in Blood about the development of MPN as it takes place in the hematopoeitic stem cell. Click here to read the abstract (full article requires purchase or login). They discuss how the mutant cells (JAK2, CALR, MPL) are dominant against normal cells.
Our understanding of the science behind MPN will contribute to our ability as a community to create better therapies and eventually a cure.